期刊
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY
卷 11, 期 6, 页码 507-521出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/17474124.2017.1312343
关键词
Infection control; clostridium difficile; primary prevention; probiotics; nosocomial; antibiotic stewardship; antibiotics; vaccines; healthcare costs
Introduction: C. difficile infections (CDI) have been a challenging disease to treat, much less to prevent, for decades. Efforts for primary prevention have mainly focused on improving infection control practices, but CDI outbreaks continue to plague healthcare facilities.Areas covered: A literature search from 1970-December 2016 found 13 facility-level and 2 patient-level strategies that were evidence-based. The aim of this manuscript is to assess the current state of the literature on primary prevention of CDI and offer insights into which strategies may be more effective.Expert commentary: The strongest evidence for primary prevention is based on multi-faceted infection control bundles, while there is promising moderate evidence involving facility-wide use of specific probiotics. Moderate-level evidence was found for patient-level use of specific probiotics and low level evidence for vaccines. Future suggestions include use of consistent outcome metrics, measurements of implementation compliance and program sustainability.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据